For instance, several studies have shown low expression of NKG2D, NCRs, and DNAM‐1as activating receptors and KIR2DL2/L3 and NKG2A overexpression as inhibitory receptors in AML patients.146. The gene discussed is KLRC1; the disease is acute myeloid leukemia.